B. Mary E. von Blomberg

Author

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

B M E VON BLOMBERG, B M E Von Blomberg, B M E von Blomberg, B M von Blomberg, B Mary E Von Blomberg, B Mary E von Blomberg, B. M. E. Blomberg, B. M. E. VON BLOMBERG, B. M. E. Von Blomberg, B. M. E. von Blomberg

138

Publications

10.1K

Citations

H-Index

123

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam University of Amsterdam Kirin (Japan)Leiden University Medical Center

About

B. Mary E. von Blomberg is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	46	4.9K
2	Allergy	7	7	386
3	Engineering	2	2	84
4	Health Sciences	2	2	421
5	Public Health	2	2	572

B. Mary E. von Blomberg

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 Bob W. van Oosten, Frederik Barkhof, L. Truyen, Neurology Immune ActivationImmunologyPathologyImmunotherapyTnf Alpha	1996	732
Underlying disorders associated with severe early-onset preeclampsia G.A. Dekker, Johanna I.P. de Vries, P.M. Doelitzsch, American Journal of Obstetrics and Gynecology Maternal Cardiovascular OutcomePreterm LaborGestational HypertensionMaternal HealthObstetric Hypertension	1995	522
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Giuseppe Giaccone, Cornelis J. A. Punt, Rita Ruijter, PubMed	2002	507
Secretion of Tumour Necrosis Factor α and Lymphotoxin α in Relation to Polymorphisms in the TNF Genes and HLA‐DR Alleles. Relevance for Inflammatory Bowel Disease J. Bart A. Crusius, M. Oudkerk Pool, J. J. Kolkman, Scandinavian Journal of Immunology	1996	378
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial Alfons JM van den Eertwegh, Jurjen Versluis, H. Pieter van den Berg, The Lancet Oncology Tumor ImmunologyUrologyMedicineMetronomic TherapyImmunology	2012	356
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience Abdulbaqi Al–Toma, Wieke H.M. Verbeek, M Hadithi, Gut	2007	326
Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage Hans van Vliet, B. Mary E. von Blomberg, Nobusuke Nishi, Clinical Immunology InflammationWide VarietyAutoimmune DiseaseImmunologyImmune Regulation	2001	270
Peripheral blood IFN‐γ‐secreting Vα24<sup>+</sup>Vβ11<sup>+</sup> NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load Johan W. Molling, Wendy Kölgen, Hans van Vliet, International Journal of Cancer	2005	229
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia Maria G. van Pampus, Gustaf A. Dekker, Hans Wolf, American Journal of Obstetrics and Gynecology Reproductive HealthGynecologySevere PreeclampsiaHigh-risk PregnancyHematology	1999	229
Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies Johanna I.P. de Vries, G.A. Dekker, P. C. Huijgensb, BJOG An International Journal of Obstetrics & Gynaecology	1997	206

Page 1